Literature DB >> 17192355

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

John B Buse1, Henry N Ginsberg, George L Bakris, Nathaniel G Clark, Fernando Costa, Robert Eckel, Vivian Fonseca, Hertzel C Gerstein, Scott Grundy, Richard W Nesto, Michael P Pignone, Jorge Plutzky, Daniel Porte, Rita Redberg, Kimberly F Stitzel, Neil J Stone.   

Abstract

The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: the ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.

Entities:  

Mesh:

Year:  2007        PMID: 17192355     DOI: 10.2337/dc07-9917

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  148 in total

1.  The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.

Authors:  Nikolaos P E Kadoglou; Grigorios Fotiadis; Zoi Athanasiadou; Ioulia Vitta; Stylianos Lampropoulos; Ioannis S Vrabas
Journal:  Endocrine       Date:  2012-03-11       Impact factor: 3.633

2.  Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia.

Authors:  H Carlijne Hassing; Hans Mooij; Shuling Guo; Brett P Monia; Keyang Chen; Wim Kulik; Geesje M Dallinga-Thie; Max Nieuwdorp; Erik S G Stroes; Kevin Jon Williams
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

Review 3.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

Review 4.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

5.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

6.  Stopping the cardiovascular disease continuum: Focus on prevention.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2010-03-26

7.  Tuning in to the ‘right’ calcium channel regulation in experimental models of diabetes.

Authors:  M Sturek
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

Review 8.  Prognostic utility of coronary computed tomographic angiography.

Authors:  Yuka Otaki; Daniel S Berman; James K Min
Journal:  Indian Heart J       Date:  2013-04-12

9.  Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Per Olav Vandvik; A Michael Lincoff; Joel M Gore; David D Gutterman; Frank A Sonnenberg; Pablo Alonso-Coello; Elie A Akl; Maarten G Lansberg; Gordon H Guyatt; Frederick A Spencer
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

10.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.